WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Sellas Life Sciences Group
Sellas Life Sciences Group
University of Nebraska
Virginia Commonwealth University
Roswell Park Cancer Institute
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center